Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.9 EUR
−8.84 M EUR
583.60 K EUR
5.23 M
About 4BASEBIO PLC ORD EUR1
Sector
Industry
CEO
Heikki Lanckriet
Website
Headquarters
Cambridge
Founded
2020
ISIN
GB00BMCLYF79
FIGI
BBG00Z5HKCB8
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 88Q is 14.3 EUR — it has increased by 0.70% in the past 24 hours. Watch 4BASEBIO PLC EO 1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange 4BASEBIO PLC EO 1 stocks are traded under the ticker 88Q.
88Q stock has risen by 0.70% compared to the previous week, the month change is a −6.54% fall, over the last year 4BASEBIO PLC EO 1 has showed a 90.67% increase.
We've gathered analysts' opinions on 4BASEBIO PLC EO 1 future price: according to them, 88Q price has a max estimate of 21.57 EUR and a min estimate of 21.57 EUR. Watch 88Q chart and read a more detailed 4BASEBIO PLC EO 1 stock forecast: see what analysts think of 4BASEBIO PLC EO 1 and suggest that you do with its stocks.
88Q stock is 0.70% volatile and has beta coefficient of 0.20. Track 4BASEBIO PLC EO 1 stock price on the chart and check out the list of the most volatile stocks — is 4BASEBIO PLC EO 1 there?
Today 4BASEBIO PLC EO 1 has the market capitalization of 225.84 M, it has decreased by −2.43% over the last week.
Yes, you can track 4BASEBIO PLC EO 1 financials in yearly and quarterly reports right on TradingView.
4BASEBIO PLC EO 1 is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
88Q net income for the last half-year is −6.76 M EUR, while the previous report showed −4.74 M EUR of net income which accounts for −42.63% change. Track more 4BASEBIO PLC EO 1 financial stats to get the full picture.
No, 88Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 84.00 employees. See our rating of the largest employees — is 4BASEBIO PLC EO 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4BASEBIO PLC EO 1 EBITDA is −8.89 M EUR, and current EBITDA margin is −1.25 K%. See more stats in 4BASEBIO PLC EO 1 financial statements.
Like other stocks, 88Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4BASEBIO PLC EO 1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 4BASEBIO PLC EO 1 technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 4BASEBIO PLC EO 1 stock shows the buy signal. See more of 4BASEBIO PLC EO 1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.